The spatio-temporal evolution of wall-bounded turbulence is characterized by high nonlinearity, multi-scale dynamics, and ...

– Fast Track designation aims to facilitate development and expedite review of drugs, such as PBGENE-DMD to treat serious conditions like Duchenne muscular dystrophy – – March 17, 2026 virtual webinar ...

The share price of San Diego based biotech Capricor Therapeutics, Inc. (CAPR) is exploding upwards today - up >450% at the time of writing, trading at a value of $37, with a market cap valuation of ...

Duchenne muscular dystrophy (DMD) causes muscle weakness that becomes more severe over time. While there is no cure, treatments can help slow the progression and manage symptoms and complications.

Duchenne muscular dystrophy (DMD) occurs as a result of genetic changes on the X chromosome. If someone has a gene change that can cause DMD, their children may inherit that change. DMD is a ...

There is no cure for DMD, but treatments can slow the progression of the disease and help improve quality of life. Duchenne muscular dystrophy (DMD) is a chronic condition that causes a gradual loss ...

Tailwind Capital has made an investment in DMD Systems Recovery, a Tempe, Arizona-based IT asset disposition solutions provider. No financial terms were disclosed. The capital infusion will be used by ...

After an unconventional public display of disapproval, the FDA has made a stunning reversal on Sarepta Therapeutics’ Elevidys, recommending that Duchenne muscular dystrophy (DMD) patients who can walk ...

The U.S. FDA has granted Precision Biosciences Inc.’s PBGENE-DMD orphan drug designation for the treatment of Duchenne muscular dystrophy (DMD). PBGENE-DMD uses two complementary Arcus nucleases ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...

DMD Ventures launched a preemptive legal strike in an attempt to stave off foreclosure of a 2-acre multifamily development site in Fort Lauderdale. On June 13, a Naples-based lending entity managed by ...

Sarepta Therapeutics said it has temporarily suspended shipments of Elevidys ® (delandistrogene moxeparvovec-rokl) for infusion in non-ambulatory patients following the second death in three months of ...